Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21)

The summary for the Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21): - The National Cancer Institute (NCI), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute of Biomedical Imaging and Biotechnology (NIBIB), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) are interested in receiving grant applications that address the etiology and etiologic mechanisms of hepatocellular carcinoma (HCC) and development of animal models, novel approaches to prevent this malignancy, and therapeutic or diagnostic studies aimed at establishing reliable prognostic indicators for disease progression and/or minimizing morbidity and mortality associated with this malignancy. - Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism types, numbers, qualities, durations, and costs of the applications received. - The types of mechanisms to be supported include traditional investigator-initiated R01 (individual) and R21 (exploratory/developmental) research grant applications. - You may submit (an) application(s) if your organization has any of the following characteristics: for-profit organizations ; non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State governments; units of local governments; eligible agencies of the Federal government; domestic institutions; foreign institutions; and faith-based or community-based organizations. - Eligible principal investigators include a ny individual with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. - Applicants may submit more than one application, provided they are scientifically distinct. - See Section IV.1 for application and submission information. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Federal Grant Title: Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (R01 and R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health Food and Nutrition
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-05-137
Type of Funding: Grant
CFDA Numbers: 93.27393.286
CFDA Descriptions: Alcohol Research Programs 93.286 Discovery and Applied Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jul 13, 2005
Creation Date: Dec 21, 2006
Archive Date: Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.393 -- Cancer Cause and Prevention Research
Applicants Eligible for this Grant
For profit organizations other than small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education State governments County governments Small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized)
Additional Information on Eligibility
Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020